BioSpace News Archive

Over the course of 2020, the biopharmaceutical industry came together to rapidly address the global COVID-19 crisis. Despite that spirit of comradery and partnership, there were still a few incidents that caused some arched eyebrows, gasps of astonishment and even fits of anger.

Antengene Corporation Limited announced that it has submitted a New Drug Application with Orphan Drug Designation to the South Korean Ministry of Food and Drug Safety for ATG-010 in combination with low dose dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma and for ATG-010 as monotherapy to treat adult patients with relapsed/refractory diffuse large B-cell lymphoma.

Cosmetic peptide synthesis needs stricter quality control so as to ensure better reproducibility, improved peptide production along with large scale capacity for peptide synthesis.

The global melanoma therapeutics market is expected to be driven by the rising cases of melanoma and many other types of skin cancers.

The oncology is rapidly embracing proton therapy for improving treatment outcomes in various types of cancer.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced that Ocumension Therapeutics, a China-based ophthalmic pharmaceutical company traded on the Stock Exchange of Hong Kong, has made a $15.7 million equity investment in EyePoint.

Manufacturers and key players in the global electromagnetic navigation bronchoscopy market have been making immense efforts in the development of highly advanced minimally invasive technologies for meeting the need of early treatment as well as diagnosis of lung cancer, a deadly disease across the globe.

The magnetic bead-based nucleic acid extraction market is predicted to witness notable growth over the forecast period from 2020 to 2030.

The report on global non-invasive brain stimulation system market comes with strong research on the said industry, which allows consumers to look at the prediction and possible requirements.

Homecare oxygen concentrators are usually used in providing supplemental oxygen to wide range of patients with respiratory problems.